PHARMACYTE BIOTECH, INC. Comprehensive Income
PHARMACYTE BIOTECH, INC. (PMCB) reported Comprehensive Income of -$5.08 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-09-14
- PHARMACYTE BIOTECH, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-07-31 was -$5.08M.
- PHARMACYTE BIOTECH, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-04-30 was -$4.39M, a 137.38% decline year-over-year.
- PHARMACYTE BIOTECH, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-01-31 was $749.45K.
- PHARMACYTE BIOTECH, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-10-31 was -$7.42M.
- PHARMACYTE BIOTECH, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2026 was -$19.42M, a 163.35% decline from fiscal 2025.
- PHARMACYTE BIOTECH, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $30.66M, a 9098.87% increase from fiscal 2024.
- PHARMACYTE BIOTECH, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $333.25K.
- PHARMACYTE BIOTECH, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$4.32M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-07-31 | -$5.08M 10-Q · filed 2026-09-14 | -$9.47M derived: sum of 2 quarters · filed 2026-09-14 | -$8.73M derived: sum of 3 quarters · filed 2026-09-14 | -$16.14M derived: sum of 4 quarters · filed 2026-09-14 | |||
| 2026-04-30 | -$4.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | -$3.64M derived: sum of 2 quarters · filed 2026-07-29 | -$11.06M derived: sum of 3 quarters · filed 2026-07-29 | -$19.42M 10-K · filed 2026-07-29 | |||
| 2026-01-31 | $749.45K 10-Q · filed 2026-03-17 | -$6.67M derived: sum of 2 quarters · filed 2026-03-17 | -$15.03M 10-Q · filed 2026-03-17 | -$3.28M derived: sum of 4 quarters · filed 2026-09-14 | |||
| 2025-10-31 | -$7.42M 10-Q · filed 2025-12-18 | -$15.78M 10-Q · filed 2025-12-18 | -$4.03M derived: sum of 3 quarters · filed 2026-09-14 | -$7.07M derived: sum of 4 quarters · filed 2026-09-14 | |||
| 2025-07-31 | -$8.36M 10-Q · filed 2026-09-14 | $3.39M derived: sum of 2 quarters · filed 2026-09-14 | $343.68K derived: sum of 3 quarters · filed 2026-09-14 | -$1.13M derived: sum of 4 quarters · filed 2026-09-14 | |||
| 2025-04-30 | $11.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $8.70M derived: sum of 2 quarters · filed 2026-07-29 | $7.23M derived: sum of 3 quarters · filed 2026-07-29 | $30.66M 10-K · filed 2026-07-29 | |||
| 2025-01-31 | -$3.05M 10-Q · filed 2026-03-17 | -$4.52M derived: sum of 2 quarters · filed 2026-03-17 | $18.91M 10-Q · filed 2026-03-17 | $20.25M derived: sum of 4 quarters · filed 2026-03-17 | |||
| 2024-10-31 | -$1.47M 10-Q · filed 2025-12-18 | $21.95M 10-Q · filed 2025-12-18 | $23.30M derived: sum of 3 quarters · filed 2025-12-18 | $22.68M derived: sum of 4 quarters · filed 2025-12-18 | |||
| 2024-07-31 | $23.42M 10-Q · filed 2025-09-15 | $24.77M derived: sum of 2 quarters · filed 2025-09-15 | $24.15M derived: sum of 3 quarters · filed 2025-09-15 | $26.94M derived: sum of 4 quarters · filed 2025-09-15 | |||
| 2024-04-30 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-11 | $727.80K derived: sum of 2 quarters · filed 2025-08-11 | $3.52M derived: sum of 3 quarters · filed 2025-08-11 | $333.25K 10-K · filed 2025-08-11 | |||
| 2024-01-31 | -$618.47K 10-Q · filed 2025-03-17 | $2.17M derived: sum of 2 quarters · filed 2025-03-17 | -$1.01M 10-Q · filed 2025-03-17 | -$1.14M derived: sum of 4 quarters · filed 2025-03-17 | |||
| 2023-10-31 | $2.79M 10-Q · filed 2024-12-13 | -$394.54K 10-Q · filed 2024-12-13 | -$526.15K derived: sum of 3 quarters · filed 2024-12-13 | -$1.29M derived: sum of 4 quarters · filed 2024-12-13 | |||
| 2023-07-31 | -$3.18M 10-Q · filed 2024-09-17 | -$3.50M 10-Q · filed 2023-09-18 | -$3.31M derived: sum of 2 quarters · filed 2024-09-17 | -$4.08M derived: sum of 3 quarters · filed 2024-09-17 | -$5.96M derived: sum of 4 quarters · filed 2024-09-17 | ||
| 2023-04-30 | -$131.61K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-13 | -$898.30K derived: sum of 2 quarters · filed 2024-08-13 | -$2.78M derived: sum of 3 quarters · filed 2024-08-13 | -$4.32M 10-K · filed 2024-08-13 | |||
| 2023-01-31 | -$766.69K 10-Q · filed 2024-03-18 | -$2.65M derived: sum of 2 quarters · filed 2024-03-18 | -$4.19M 10-Q · filed 2024-03-18 | -$5.61M derived: sum of 4 quarters · filed 2024-03-18 | |||
| 2022-10-31 | -$1.88M 10-Q · filed 2023-12-15 | -$3.42M 10-Q · filed 2023-12-15 | -$4.84M derived: sum of 3 quarters · filed 2023-12-15 | -$5.66M derived: sum of 4 quarters · filed 2023-12-15 | |||
| 2022-07-31 | -$1.54M 10-Q · filed 2023-09-18 | -$2.96M derived: sum of 2 quarters · filed 2023-09-18 | -$3.77M derived: sum of 3 quarters · filed 2023-09-18 | -$4.75M derived: sum of 4 quarters · filed 2023-09-18 | |||
| 2022-04-30 | -$1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-31 | -$2.23M derived: sum of 2 quarters · filed 2023-07-31 | -$3.21M derived: sum of 3 quarters · filed 2023-07-31 | -$4.23M 10-K · filed 2023-07-31 | |||
| 2022-01-31 | -$811.50K 10-Q · filed 2023-03-16 | -$1.79M derived: sum of 2 quarters · filed 2023-03-16 | -$2.82M 10-Q · filed 2023-03-16 | -$3.77M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-10-31 | -$976.84K 10-Q · filed 2022-12-14 | -$2.00M 10-Q · filed 2022-12-14 | -$2.96M derived: sum of 3 quarters · filed 2022-12-14 | -$3.72M derived: sum of 4 quarters · filed 2022-12-14 | |||
| 2021-07-31 | -$1.03M 10-Q · filed 2022-09-14 | -$1.99M derived: sum of 2 quarters · filed 2022-09-14 | -$2.74M derived: sum of 3 quarters · filed 2022-09-14 | -$3.69M derived: sum of 4 quarters · filed 2022-09-14 | |||
| 2021-04-30 | -$959.37K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-28 | -$1.72M derived: sum of 2 quarters · filed 2022-07-28 | -$2.66M derived: sum of 3 quarters · filed 2022-07-28 | -$3.55M 10-K · filed 2022-07-28 | |||
| 2021-01-31 | -$756.23K 10-Q · filed 2022-03-15 | -$1.70M derived: sum of 2 quarters · filed 2022-03-15 | -$2.59M 10-Q · filed 2022-03-15 | -$3.34M derived: sum of 4 quarters · filed 2022-03-15 | |||
| 2020-10-31 | -$947.34K 10-Q · filed 2021-12-14 | -$1.83M 10-Q · filed 2021-12-14 | -$2.58M derived: sum of 3 quarters · filed 2021-12-14 | -$3.46M derived: sum of 4 quarters · filed 2021-12-14 | |||
| 2020-07-31 | -$881.27K 10-Q · filed 2021-09-14 | -$1.63M derived: sum of 2 quarters · filed 2021-09-14 | -$2.51M derived: sum of 3 quarters · filed 2021-09-14 | -$3.58M derived: sum of 4 quarters · filed 2021-09-14 | |||
| 2020-04-30 | -$750.72K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-10 | -$1.63M derived: sum of 2 quarters · filed 2021-08-10 | -$2.69M derived: sum of 3 quarters · filed 2021-08-10 | -$3.83M 10-K · filed 2021-08-10 | |||
| 2020-01-31 | -$875.91K 10-Q · filed 2021-03-12 | -$1.94M derived: sum of 2 quarters · filed 2021-03-12 | -$3.08M 10-Q · filed 2021-03-12 | -$4.23M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2019-10-31 | -$1.07M 10-Q · filed 2020-12-11 | -$2.21M 10-Q · filed 2020-12-11 | -$3.35M derived: sum of 3 quarters · filed 2020-12-11 | -$4.03M derived: sum of 4 quarters · filed 2020-12-11 | |||
| 2019-07-31 | -$1.14M 10-Q · filed 2020-09-11 | -$2.29M derived: sum of 2 quarters · filed 2020-09-11 | -$2.96M derived: sum of 3 quarters · filed 2020-09-11 | -$4.00M derived: sum of 4 quarters · filed 2020-09-11 | |||
| 2019-04-30 | -$1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | -$1.82M derived: sum of 2 quarters · filed 2020-08-13 | -$2.86M derived: sum of 3 quarters · filed 2020-08-13 | -$4.08M 10-K · filed 2020-08-13 | |||
| 2019-01-31 | -$672.80K 10-Q · filed 2020-03-13 | -$1.72M derived: sum of 2 quarters · filed 2020-03-13 | -$2.93M 10-Q · filed 2020-03-13 | -$4.23M derived: sum of 4 quarters · filed 2020-03-13 | |||
| 2018-10-31 | -$1.04M 10-Q · filed 2019-12-23 | -$2.26M 10-Q · filed 2019-12-23 | -$3.56M derived: sum of 3 quarters · filed 2019-12-23 | -$5.59M derived: sum of 4 quarters · filed 2019-12-23 | |||
| 2018-07-31 | -$1.22M 10-Q · filed 2019-09-13 | -$2.52M derived: sum of 2 quarters · filed 2019-09-13 | -$4.55M derived: sum of 3 quarters · filed 2019-09-13 | -$6.36M derived: sum of 4 quarters · filed 2019-09-13 | |||
| 2018-04-30 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | -$3.33M derived: sum of 2 quarters · filed 2019-08-13 | -$5.15M derived: sum of 3 quarters · filed 2019-08-13 | -$6.84M 10-K · filed 2019-08-13 | |||
| 2018-01-31 | -$2.03M 10-Q · filed 2019-03-14 | -$2.03M 10-Q · filed 2018-03-19 | -$3.85M derived: sum of 2 quarters · filed 2019-03-14 | -$5.53M 10-Q · filed 2019-03-14 | -$6.69M derived: sum of 4 quarters · filed 2019-03-14 | ||
| 2017-10-31 | -$1.81M 10-Q · filed 2018-12-14 | -$3.50M 10-Q · filed 2018-12-14 | -$4.66M derived: sum of 3 quarters · filed 2018-12-14 | -$5.94M derived: sum of 4 quarters · filed 2018-12-14 | |||
| 2017-07-31 | -$1.69M 10-Q · filed 2018-09-12 | -$2.85M derived: sum of 2 quarters · filed 2018-09-12 | -$4.13M derived: sum of 3 quarters · filed 2018-09-12 | -$5.10M derived: sum of 4 quarters · filed 2018-09-12 | |||
| 2017-04-30 | -$1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-20 | -$2.44M derived: sum of 2 quarters · filed 2018-07-20 | -$3.41M derived: sum of 3 quarters · filed 2018-07-20 | -$4.44M 10-K · filed 2018-07-20 | |||
| 2017-01-31 | -$1.28M 10-Q · filed 2018-03-19 | -$2.26M derived: sum of 2 quarters · filed 2018-03-19 | -$3.29M 10-Q · filed 2018-03-19 | -$4.41M derived: sum of 4 quarters · filed 2018-03-19 | |||
| 2016-10-31 | -$974.94K 10-Q · filed 2017-12-14 | -$2.01M 10-Q · filed 2017-12-14 | -$3.13M derived: sum of 3 quarters · filed 2017-12-14 | -$4.92M derived: sum of 4 quarters · filed 2017-12-14 | |||
| 2016-07-31 | -$1.03M 10-Q · filed 2017-09-13 | -$2.16M derived: sum of 2 quarters · filed 2017-09-13 | -$3.95M derived: sum of 3 quarters · filed 2017-09-13 | -$5.58M derived: sum of 4 quarters · filed 2017-09-13 | |||
| 2016-04-30 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-27 | -$2.92M derived: sum of 2 quarters · filed 2017-07-27 | -$4.55M derived: sum of 3 quarters · filed 2017-07-27 | -$6.06M 10-K · filed 2017-07-27 | |||
| 2016-01-31 | -$1.79M 10-Q · filed 2017-03-13 | -$3.43M derived: sum of 2 quarters · filed 2017-03-13 | -$4.94M 10-Q · filed 2017-03-13 | -$7.76M derived: sum of 4 quarters · filed 2017-03-13 | |||
| 2015-10-31 | -$1.64M 10-Q · filed 2016-12-02 | -$1.10M 10-Q · filed 2015-12-10 | -$3.15M 10-Q · filed 2016-12-02 | -$1.64M 10-Q · filed 2015-12-10 | -$5.97M derived: sum of 3 quarters · filed 2016-12-02 | -$7.43M derived: sum of 4 quarters · filed 2016-12-02 | |
| 2015-07-31 | -$1.52M 10-Q · filed 2016-09-06 | -$547.78K 10-Q · filed 2015-08-25 | -$4.34M derived: sum of 2 quarters · filed 2016-09-06 | -$5.79M derived: sum of 3 quarters · filed 2016-09-06 | -$9.86M derived: sum of 4 quarters · filed 2016-09-06 | ||
| 2015-04-30 | -$2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | -$4.28M derived: sum of 2 quarters · filed 2016-07-29 | -$8.34M derived: sum of 3 quarters · filed 2016-07-29 | -$9.93M 10-K · filed 2016-07-29 | -$10.85M 10-K · filed 2015-07-29 | ||
| 2015-01-31 | -$1.46M 10-Q · filed 2016-03-08 | -$5.52M derived: sum of 2 quarters · filed 2016-03-08 | -$7.11M 10-Q · filed 2016-03-08 | ||||
| 2014-10-31 | -$4.06M 10-Q/A · filed 2016-01-19 | -$5.65M 10-Q/A · filed 2016-01-19 | |||||
| 2014-07-31 | -$1.58M 10-Q/A · filed 2016-01-19 | ||||||
| 2014-04-30 | -$27.25M 10-K · filed 2016-07-29 | ||||||
| 2013-04-30 | -$1.60M 10-K/A · filed 2016-01-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |